U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019516

Expand all

MS CONTIN (MORPHINE SULFATE)
15MG
Marketing Status: Prescription
Active Ingredient: MORPHINE SULFATE
Proprietary Name: MS CONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 15MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019516
Product Number: 003
Approval Date: Sep 12, 1989
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information
MS CONTIN (MORPHINE SULFATE)
30MG
Marketing Status: Prescription
Active Ingredient: MORPHINE SULFATE
Proprietary Name: MS CONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019516
Product Number: 001
Approval Date: May 29, 1987
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information
MS CONTIN (MORPHINE SULFATE)
60MG
Marketing Status: Prescription
Active Ingredient: MORPHINE SULFATE
Proprietary Name: MS CONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019516
Product Number: 002
Approval Date: Apr 8, 1988
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information
MS CONTIN (MORPHINE SULFATE)
100MG
Marketing Status: Prescription
Active Ingredient: MORPHINE SULFATE
Proprietary Name: MS CONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N019516
Product Number: 004
Approval Date: Jan 16, 1990
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information
MS CONTIN (MORPHINE SULFATE)
200MG
Marketing Status: Prescription
Active Ingredient: MORPHINE SULFATE
Proprietary Name: MS CONTIN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019516
Product Number: 005
Approval Date: Nov 8, 1993
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top